Hydroxyethyl Starch Solutions Should Not Be Used in Some Critically Ill Patients
(firmenpresse) - OTTAWA, ONTARIO -- (Marketwired) -- 06/24/13 -- Health Canada and the manufacturers of blood volume expanders containing hydroxyethyl starch (HES) solutions recommend that these products no longer be used in critically ill patients with certain health conditions.
HES solutions are used to replace lost blood in patients who are critically ill and experience a sudden drop in blood pressure (for example, following surgery).
Specifically, HES solutions should not be used:
Some recent studies have compared HES with other blood volume expanders in critically ill patients with sepsis. These studies suggest that patients treated with HES are at a higher risk of kidney failure or death.
Health Canada will work with the manufacturers to update the drug labels of these products and will communicate with healthcare professionals and consumers when the labels have been updated.
Egalement disponible en francais
Contacts:
Media Inquiries:
Health Canada
613-957-2983
Public Inquiries:
613-957-2991
1-866-225-0709
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 24.06.2013 - 12:45 Uhr
Sprache: Deutsch
News-ID 1239675
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
OTTAWA, ONTARIO
Phone:
Kategorie:
Government & Administration
Anmerkungen:
Diese Pressemitteilung wurde bisher 182 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Hydroxyethyl Starch Solutions Should Not Be Used in Some Critically Ill Patients
"
steht unter der journalistisch-redaktionellen Verantwortung von
Health Canada (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
